HRTX Heron Therapeutics, Inc.

Fundamentals / CIK 0000818033 / USD

Heron Therapeutics, Inc. reported $148.2M in revenue and a net loss of $21.56M for the trailing twelve months ended September 30, 2026 (down 7.8% year over year), with a 71.5% gross margin and a -5.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HRTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$176.7M$88.34M$0-$225.7MFY 2016 Revenue: $1.28MFY 2016 Net Income: -$173.1M2016FY 2017 Revenue: $30.77MFY 2017 Net Income: -$197.5M2017FY 2018 Revenue: $77.47MFY 2018 Net Income: -$178.8M2018FY 2019 Revenue: $146.0MFY 2019 Net Income: -$204.7M2019FY 2020 Revenue: $88.64MFY 2020 Net Income: -$227.3M2020FY 2021 Revenue: $86.35MFY 2021 Net Income: -$220.7M2021FY 2022 Revenue: $107.7MFY 2022 Net Income: -$182.0M2022FY 2023 Revenue: $127.0MFY 2023 Net Income: -$110.6M2023FY 2024 Revenue: $144.3MFY 2024 Net Income: -$13.58M2024FY 2025 Revenue: $154.9MFY 2025 Net Income: -$20.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $154.9M $144.3M $127.0M $107.7M $86.35M $88.64M $146.0M $77.47M $30.77M $1.28M
Cost of Revenue $41.35M $38.65M $65.11M $54.87M $46.02M $36.19M $61.62M $27.51M $4.59M $35K
Gross Profit $113.6M $105.6M $61.94M $52.80M $40.33M $52.45M $84.35M $49.96M $26.18M $1.24M
Research & Development $12.43M $16.68M $39.13M $82.70M $130.8M $174.5M $167.4M $140.0M $138.6M $103.1M
Selling, General & Admin $103.7M $100.5M $133.4M $144.8M $127.3M $106.1M $127.7M $93.87M $82.16M $69.03M
Total Operating Expenses -- -- -- -- -- -- -- $261.4M $225.3M $172.2M
Operating Income -$2.54M -$11.53M -$110.6M -$174.7M -$217.8M -$228.2M -$210.7M -$183.9M -$194.6M -$170.9M
EBITDA -$224K -$9.04M -$107.7M -$171.8M -$214.8M -$225.3M -$208.7M -$182.4M -$193.0M -$169.8M
Interest Income $1.95M $3.55M $3.36M $1.64M $433K $3.63M $7.26M $5.96M $1.05M $445K
Interest Expense $9.61M $6.03M $3.87M $2.47M $2.41M $1.90M $1.47M $2.67M $3.94M $2.66M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$20.20M -$13.58M -$110.6M -$182.0M -$220.7M -$227.3M -$204.7M -$178.8M -$197.5M -$173.1M
Basic EPS -$0.12 -$0.09 -$0.80 -$1.67 -$2.24 -$2.50 -$2.50 -$2.44 -$3.65 -$4.56
Diluted EPS -$0.12 -$0.09 -$0.80 -$1.67 -$2.24 -$2.50 -$2.50 -$2.44 -$3.65 -$4.56
Basic Shares Outstanding 166.7M 152.4M 138.1M 108.9M 98.5K 90.8M 81.8M 73.2M 54.0M 37.9M
Diluted Shares Outstanding 166.7M 152.4M 138.1M 108.9M 98.5K 90.8M 81.8M 73.2M 54.0M 37.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $35.25M $37.67M $34.71M $40.59M $38.21M $37.20M $38.90M $40.78M
Cost of Revenue $8.96M $11.57M $10.64M $11.12M $11.91M $9.86M $8.46M $10.23M
Gross Profit $26.29M $26.09M $24.07M $29.47M $26.30M $27.34M $30.45M $30.55M
Research & Development $3.10M $2.70M $2.38M $3.75M $3.47M $2.93M $2.28M $3.18M
Selling, General & Admin $24.86M $25.44M $26.45M $25.68M $26.92M $26.05M $25.01M $23.20M
Operating Income -$1.67M -$2.04M -$4.76M $38K -$4.09M -$1.64M $3.15M $4.17M
EBITDA -$1.28M -$1.59M -$4.24M $575K -$3.48M -$1.03M $3.71M $4.75M
Net Income -$5.01M -$5.49M -$8.11M -$2.95M -$17.50M -$2.38M $2.63M $3.66M
Basic EPS -$0.03 -$0.03 -$0.04 -- -$0.10 -$0.02 $0.02 --
Diluted EPS -$0.03 -$0.03 -$0.04 -- -$0.10 -$0.02 $0.01 --
Basic Shares Outstanding 190.9M 190.3M 189.6M -- 170.3M 154.0M 153.5M --
Diluted Shares Outstanding 190.9M 190.3M 189.6M -- 170.3M 154.0M 196.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $28.65M $25.80M $28.68M $15.36M $90.54M $105.1M $71.90M $31.84M $144.6M $13.41M
Short-Term Investments $17.98M $33.48M $51.73M $69.49M $67.04M $103.4M $319.1M $300.5M -- --
Cash & Short-Term Investments $46.60M $59.30M $80.40M $84.90M $157.6M $208.5M $391.0M $332.4M $172.4M $51.10M
Accounts Receivable, Net $89.59M $78.88M $60.14M $52.05M $35.50M $41.85M $39.88M $64.65M $41.87M $1.96M
Inventory $92.75M $53.16M $42.11M $54.57M $48.38M $41.91M $24.97M $39.03M $10.11M $5.34M
Total Current Assets $238.1M $209.0M $188.8M $205.4M $254.4M $314.2M $479.1M $447.2M $228.1M $62.14M
Property, Plant & Equipment, Net $12.40M $14.86M $20.17M $22.16M $23.73M $22.74M $19.62M $14.68M $5.98M $5.08M
Other Non-Current Assets $5.41M $6.48M $8.13M $15.71M $17.72M $346K $346K $254K $263K $263K
Total Non-Current Assets $17.81M $24.13M $33.73M $45.52M $51.28M $39.36M $33.72M $14.93M $6.24M $5.34M
Total Assets $255.9M $233.1M $222.5M $251.0M $305.7M $353.6M $512.8M $462.2M $234.3M $67.48M
Accounts Payable $8.99M $11.71M $3.24M $3.23M $3.80M $525K $2.76M $16.86M $18.77M $6.81M
Deferred Revenue (Current) -- -- -- -- -- -- -- -- $2.76M $1.10M
Total Current Liabilities $96.10M $91.46M $79.69M $82.36M $71.06M $102.5M $96.70M $92.02M $103.2M $38.73M
Other Non-Current Liabilities $4.81M $615K $241K $241K -- -- -- -- -- --
Total Non-Current Liabilities $145.4M $175.3M $176.8M $155.0M $157.1M $14.56M $12.24M $0 $0 $50.00M
Total Liabilities $241.5M $266.8M $256.5M $237.4M $228.1M $117.1M $108.9M $92.02M $103.2M $88.73M
Total Debt (incl. Leases) -- $3.04M $5.88M $8.19M $10.41M $17.56M $14.17M -- -- --
Common Stock $1.88M $1.52M $1.50M $1.19M $1.02M $913K $903K $782K $646K $394K
Retained Earnings -$1.94B -$1.92B -$1.91B -$1.80B -$1.61B -$1.39B -$1.17B -$960.7M -$783.5M -$586.0M
Accumulated Other Comp. Income $4.0K $13K $13K -$19K -$6.0K $257K $85K -$87K -$10K -$17K
Total Stockholders' Equity $14.33M -$33.65M -$33.97M $13.57M $77.57M $236.5M $403.8M $370.2M $131.1M -$21.25M
Total Equity $14.33M -$33.65M -$33.97M $13.57M $77.57M $236.5M $403.8M $370.2M $131.1M -$21.25M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $11.60M $20.72M $26.12M $28.65M $43.07M $16.52M $19.27M $25.80M
Short-Term Investments $11.85M $21.94M $18.67M $17.98M $12.42M $24.12M $31.41M $33.48M
Cash & Short-Term Investments $23.40M $42.70M $44.80M $46.60M $55.50M $40.60M $50.70M $59.30M
Accounts Receivable, Net $86.73M $89.57M $83.69M $89.59M $81.05M $79.93M $78.74M $78.88M
Inventory $91.30M $90.58M $92.54M $92.75M $70.03M $72.97M $56.93M $53.16M
Total Current Assets $209.1M $229.8M $229.0M $238.1M $229.4M $210.9M $212.8M $209.0M
Property, Plant & Equipment, Net $11.08M $11.81M $12.03M $12.40M $12.96M $13.68M $14.54M $14.86M
Other Non-Current Assets $4.81M $5.01M $5.21M $5.41M $5.88M $6.08M $6.28M $6.48M
Total Non-Current Assets $21.34M $22.42M $17.23M $17.81M $19.55M $21.17M $22.91M $24.13M
Total Assets $230.4M $252.3M $246.2M $255.9M $248.9M $232.1M $235.8M $233.1M
Accounts Payable $8.38M $11.64M $8.97M $8.99M $12.02M $12.04M $12.33M $11.71M
Total Current Liabilities $89.85M $92.14M $90.52M $96.10M $89.71M $258.6M $88.56M $91.46M
Other Non-Current Liabilities $4.31M $5.05M $4.93M $4.81M $4.69M $747K $682K $615K
Total Non-Current Liabilities $135.7M $153.2M $146.6M $145.4M $144.4M $747K $175.6M $175.3M
Total Liabilities $225.5M $245.4M $237.1M $241.5M $234.1M $259.3M $264.2M $266.8M
Total Debt (incl. Leases) $5.72M $5.70M -- -- $780K $1.54M $2.29M $3.04M
Common Stock $1.90M $1.90M $1.89M $1.88M $1.83M $1.53M $1.52M $1.52M
Retained Earnings -$1.96B -$1.95B -$1.95B -$1.94B -$1.94B -$1.92B -$1.92B -$1.92B
Accumulated Other Comp. Income -$7.0K -$6.0K -$6.0K $4.0K $0 -$1.0K $1.0K $13K
Total Stockholders' Equity $4.92M $6.91M $9.14M $14.33M $14.88M -$27.26M -$28.45M -$33.65M
Total Equity $4.92M $6.91M $9.14M $14.33M $14.88M -$27.26M -$28.45M -$33.65M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.20M -$13.58M -$110.6M -$182.0M -$220.7M -$227.3M -$204.7M -$178.8M -$197.5M -$173.1M
Depreciation & Amortization $2.31M $2.49M $2.90M $2.89M $3.02M $2.85M $2.04M $1.51M $1.53M $1.10M
Stock-Based Compensation $10.34M $12.96M $32.85M $42.98M $46.85M $50.22M $51.41M $33.37M $30.54M $25.96M
Change in Receivables -$10.71M -$18.74M -$8.09M -$16.55M $6.35M -$1.97M $24.77M -$22.78M -$39.91M -$1.96M
Change in Inventory -$31.05M -$11.05M $12.46M -$6.19M -$6.48M -$16.94M $14.06M -$29.12M -$4.77M -$5.34M
Change in Payables -$2.71M $8.47M $15K -$578K $3.28M -$2.23M -$14.11M -$1.91M $11.96M $3.51M
Operating Cash Flow -$27.59M -$22.53M -$58.79M -$146.9M -$203.4M -$184.8M -$124.6M -$191.8M -$170.3M -$134.1M
Capital Expenditure -$317K -$1.71M -$1.54M -$1.82M -$3.02M -$6.81M -$7.15M -$9.17M -$2.55M -$3.13M
Free Cash Flow -$27.91M -$24.23M -$60.33M -$148.7M -$206.4M -$191.6M -$131.7M -$201.0M -$172.9M -$137.2M
Purchases of Investments -$50.79M -$103.1M -$87.66M -$145.7M -$129.2M -$134.0M -$477.0M -$497.1M -$121.6M --
Investing Cash Flow $16.01M $18.71M $18.00M -$3.32M $32.73M $209.0M -$21.78M -$278.6M $7.74M $14.88M
Common Stock Issued $18.31M -- $29.75M $75.14M -- -- $162.2M $363.1M $306.3M --
Financing Cash Flow $14.43M $940K $54.11M $75.06M $156.0M $9.11M $186.4M $357.6M $293.7M $57.45M
Net Change in Cash $2.85M -$2.88M $13.31M -$75.18M -$14.60M $33.24M $40.06M -$112.7M $131.2M -$61.77M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.01M -$5.49M -$8.11M -$2.95M -$17.50M -$2.38M $2.63M $3.66M
Depreciation & Amortization $391K $452K $529K $537K $615K $611K $551K $581K
Stock-Based Compensation $3.08M $3.18M $2.98M $2.18M $2.85M $2.80M $2.51M $2.29M
Change in Receivables $2.84M -$5.88M $5.89M -$8.54M -$1.12M -$1.20M $145K -$11.84M
Change in Inventory -$735K -$683K -$169K -$14.19M $2.94M -$16.03M -$3.77M -$7.21M
Change in Payables -$3.16M $2.57M -$24K -$3.02M -$20K -$296K $624K $1.52M
Operating Cash Flow -$794K -$2.21M -$1.54M -$9.18M $1.33M -$10.87M -$8.87M -$11.78M
Capital Expenditure -$102K -$138K -$391K $0 $0 -$208K -$109K --
Free Cash Flow -$896K -$2.35M -$1.93M -$9.18M $1.33M -$11.08M -$8.98M --
Purchases of Investments -$6.04M -$14.72M -$13.14M -$12.57M -$6.13M -$9.19M -$22.90M -$12.34M
Investing Cash Flow $10.09M -$3.27M -$939K -$5.46M $11.86M $7.33M $2.27M $11.42M
Financing Cash Flow -$18.43M $82K -$51K $219K $13.36M $781K $64K $423K
Net Change in Cash -$9.13M -$5.40M -$2.53M -$14.42M $26.55M -$2.75M -$6.53M $61K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 73.3% 73.2% 48.8% 49.0% 46.7% 59.2% 57.8% 64.5% 85.1% 97.3%
Operating Margin -1.6% -8.0% -87.1% -162.2% -252.3% -257.4% -144.3% -237.4% -632.4% -13363.2%
Net Profit Margin -13.0% -9.4% -87.0% -169.1% -255.6% -256.4% -140.3% -230.8% -641.9% -13537.4%
Return on Equity (ROE) -140.9% -- -- -1341.2% -284.5% -96.1% -50.7% -48.3% -150.6% --
Return on Assets (ROA) -7.9% -5.8% -49.7% -72.5% -72.2% -64.3% -39.9% -38.7% -84.3% -256.6%
Current Ratio 2.48x 2.29x 2.37x 2.49x 3.58x 3.07x 4.95x 4.86x 2.21x 1.60x
Quick Ratio 1.51x 1.70x 1.84x 1.83x 2.90x 2.66x 4.70x 4.44x 2.11x 1.47x
Debt to Equity -- -- -- 0.60x 0.13x 0.07x 0.04x -- -- --
Revenue Growth (YoY) +7.4% +13.6% +18.0% +24.7% -2.6% -39.3% +88.4% +151.8% +2305.6% --
Gross Profit Growth (YoY) +7.5% +70.6% +17.3% +30.9% -23.1% -37.8% +68.8% +90.8% +2004.4% --
5Y Revenue / Share Growth -4.8% -47.0% -13.1% +73.7% +2599993.2% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 71.5% 70.1% 71.1% 73.3% 73.9% 74.6% 74.0% 73.2%
Operating Margin -5.7% -7.2% -6.9% -1.6% 1.0% 0.8% -2.4% -8.0%
Net Profit Margin -14.5% -22.5% -20.5% -13.0% -8.8% -0.6% -5.2% -9.4%
Return on Equity (ROE) -438.6% -492.9% -338.6% -140.9% -91.2% -- -- --
Return on Assets (ROA) -9.4% -13.5% -12.6% -7.9% -5.5% -0.4% -3.3% -5.8%
Current Ratio 2.33x 2.49x 2.53x 2.48x 2.56x 0.82x 2.40x 2.29x
Quick Ratio 1.31x 1.51x 1.51x 1.51x 1.78x 0.53x 1.76x 1.70x
Debt to Equity 1.16x 0.83x -- -- 0.05x -- -- --
Revenue Growth (YoY) -7.8% +1.3% -10.8% -0.5% +16.5% +3.3% +12.2% +19.1%
Gross Profit Growth (YoY) 0.0% -4.6% -20.9% -3.5% +12.6% +7.2% +16.1% +25.5%
Operating Income Growth (YoY) -- -- -251.1% -99.1% -- -- -- --
Net Income Growth (YoY) -- -- -407.8% -180.6% -- -- -- --
EPS Growth (YoY) -- -- -300.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -159.7% -- -- -- -60.5% -- -- -579.8%
Free Cash Flow Growth (YoY) -167.3% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0000818033) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal